Minomic Archives - Page 2 of 3

Doc Lab Partnership Announcement

by Minomic | Aug 24, 2025

We’re thrilled to announce our strategic partnership with Doc Lab Incorporated! Doc Lab has been named a Top 10 Lab Management Company by Med Health. The Game-Changer: Through our collaboration with Doc Lab, MiCheck® Prostate is now available right in your...

Minomic at AUA 2025

by Minomic | Apr 30, 2025

Minomic Inc attended the 120th American Urological Association Annual Meeting in Las Vegas on 26-29 April — a key global gathering for urology leaders and innovators. CEO of Minomic Inc, Sushmita Utpala, had the opportunity to meet with two incredible leaders shaping...

Minomic Inc Ushers in a New Era of Growth in U.S. with Sushmita Utpala as CEO of Minomic Inc!

by Minomic | Mar 20, 2025

We are thrilled to announce a significant milestone in Minomic’s journey: the appointment of Sushmita Utpala as our new Minomic Inc.’s Chief Executive Officer! After a period of dedicated preparation, we are eager to share this exciting news and the vision that...

Asia Summit on Global Health in Hong Kong

by Minomic | May 17, 2024

David Burdis is attending the Asia Summit on Global Health in Hong Kong as part of the Investment NSW delegation. During this event, he has been able to present the benefits of MiCheck® Prostate to numerous interested parties including Professor Chung-Mau Lo, HK...

New Peer-Reviewed Paper on MiCheck^® Prostate

by Minomic | Oct 5, 2023

Minomic is pleased to announce the publication of the company’s latest research paper supporting the utilisation of MiCheck® Prostate as an aid to diagnosing clinically significant prostate cancer. It is clear there is strong clinical need to identify those patients...

Dr Brad Walsh’s interview on Australia’s leading business and finance streaming service AusBiz

by Minomic | Oct 3, 2023

Last Thursday Dr Brad Walsh was interviewed on Australia’s leading business and finance streaming service, AusBiz by renowned TV personality David Koch about Minomic’s technology and future plans as a fitting end to Prostate Cancer Awareness Month. You can view...

« Older Entries

Next Entries »

PUBLICATIONS

Australian MiCheck^® Prostate White Paper 2026

Detection of rare prostate cancer cells in human urine offers prospect of non-invasive diagnosis. Sayyadi, N, Justiniano, I, Wang, Y, Zheng, X, Zhang, W, Jiang, L, Polikarpov, DM, Willows, RD, Gillatt, D, Campbell, D, Walsh, BJ, Yuan, J, Lu, Y, Packer, NH, Wang, Y & Piper, JA 2022. Scientific Reports, vol. 12, no. 1, 18452.

Cancer-derived small extracellular vesicles: emerging biomarkers and therapies for pancreatic ductal adenocarcinoma diagnosis/prognosis and treatment. Zhang, W, Campbell, DH, Walsh, BJ, Packer, NH, Liu, D & Wang, Y 2022. Journal of Nanobiotechnology, vol. 20, no. 1, 446.

Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-of-concept study. Wei Zhang, Ling Wang, Dan Li, Douglas H. Campbell, Bradley J. Walsh, et al. RSC. 2022.

Development and evaluation of the MiCheck test for aggressive prostate cancer. Shore ND, Pieczonka CM, Henderson RJ, Bailen JL, Saltzstein DR, Concepcion RS, et al. Urol Oncol Semin Orig Investig. 2020.

A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population—The MiCheck-01 prospective trial Shore ND, Pieczonka CM, Henderson RJ, Bailen JL, Saltzstein DR, Concepcion RS, et al. Urol Oncol. 2020.

The Role of Glypican-1 in the Tumour Microenvironment. Lund ME, Campbell DH, Walsh BJ. Adv Exp Med Biol. 2020.

Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer. Campbell DH, Lund ME, Nocon AL, Cozzi PJ, Frydenberg M, De Souza P, et al. PLoS One. 2018.

Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker. Levin RA, Lund ME, Truong Q, Wu A, Shore ND, Saltzstein DR, et al. Oncotarget. 2018.

Glypican-1 as a biomarker for prostate cancer: Isolation and characterization. Truong Q, Justiniano IO, Nocon AL, Soon JT, Wissmueller S, Campbell DH, et al. J Cancer. 2016.

PATENTS

Minomic Patent Estate